Pharmacovigilance in Older Adults

Author:

Gomes Daniel,Rebelo Gomes Eva,Ribeiro-Vaz Inês,Teresa Herdeiro Maria,Roque Fátima

Abstract

Polypharmacy and physiological changes inherent to the aging process can cause significant modifications in the pharmacokinetic and dynamic regimens of drugs, making the elderly more susceptible to adverse drug effects. Adverse drug reactions (ADR) in older adults have a significant impact on hospital admissions, increasing hospital stay and healthcare costs. Most common ADR in this population are dose-related and predictable. However, they can be difficult to diagnose as they often have nonspecific symptoms. This could be minimized by decreasing the use and prescription of potentially inappropriate medication and being aware of possible drug interactions. Besides, being older patients underrepresented in clinical trials and due to their physiological modifications, serious or atypical ADR are more common in this age range. To minimize harm in older adults, effective pharmacovigilance must be encouraged.

Publisher

IntechOpen

Reference71 articles.

1. World Health Organization. The Pursuit of Responsible Use of Medicines: Sharing and Learning from Country Experiences The benefits of responsible use of medicines: Setting policies for better and cost-effective health care [Internet]. 2012 [cited 2020 Nov 29]. Available from: www.who.int

2. FDA. Think It Through: Managing the Benefits and Risks of Medicines | FDA [Internet]. [cited 2020 Nov 29]. Available from: https://www.fda.gov/drugs/drug-information-consumers/think-it-through-managing-benefits-and-risks-medicines

3. UMC | The story of UMC and the WHO programme [Internet]. [cited 2020 Nov 30]. Available from: https://www.who-umc.org/global-pharmacovigilance/who-programme-for-international-drug-monitoring/the-story-of-umc-and-the-who-programme/

4. World Health Organization. Global Health and Aging. Global Health and Aging. 2011.

5. Atella V, Mortari AP, Kopinska J, Federico Belotti |, Lapi F, Cricelli C, et al. Trends in age-related disease burden and healthcare utilization. Aging Cell. 2018;

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3